Seven-day contraceptive patch: Phase III started

Agile Therapeutics began an open-label, U.S Phase III trial to compare AG200-15 vs. low dose oral contraceptives in up to 1,500 women ages 17-40. AG200-15 will be applied once weekly for 3 weeks follo...